HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Y-0452

PPARalpha agonist for treatment of Diabetic Retinopathy structure in first source

Also Known As:

7-chloro-8-methyl-2-phenylquinoline-4-carboxylic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Chlorinated Hydrocarbons: 240
      - Y-0452: 1
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Y-0452: 1

Experts

1.	Chen, Danyang: 1 article (10/2017)
2.	Cheng, Rui: 1 article (10/2017)
3.	Deng, Guotao: 1 article (10/2017)
4.	Ma, Jian-Xing: 1 article (10/2017)
5.	Matlock, Greg: 1 article (10/2017)
6.	Moran, David: 1 article (10/2017)
7.	Moran, Elizabeth P: 1 article (10/2017)
8.	Yu, Qiang: 1 article (10/2017)
9.	Zhou, Kelu: 1 article (10/2017)

Related Diseases

1.	Leukostasis 10/01/2017 - "In diabetic rats, Y-0452 ameliorated leukostasis and vascular leakage in the retina. "
2.	Retinal Neovascularization 10/01/2017 - "Y-0452 also alleviated retinal neovascularization in the OIR model. "